PNEUMONIA, BACTERIAL

This study is testing a new version of a pneumonia vaccine called PnMAPS30plus in healthy adults aged 50 to 64. About 120 participants will receive one dose of either the new vaccine or an already approved one and be followed for about six months. The main goals are to check if t…

This early-stage study aims to check if a new experimental pneumonia vaccine is safe for toddlers. It will involve 45 healthy children aged 12-15 months who have already had their standard baby pneumonia shots. Researchers will compare side effects from the new vaccine to those f…

This study aims to check if a new experimental pneumonia vaccine is safe for babies. It will involve 60 healthy infants, starting at about 2 months old. Researchers will compare the new vaccine to an existing one, watching closely for any side effects like fever, redness, or slee…

This is an early safety study testing a new drug called MP101 for adults with a specific, hard-to-treat bacterial pneumonia caused by Pseudomonas aeruginosa. The main goal is to see if MP101 is safe and how it behaves in the body when given alongside standard antibiotics. It's a …

This study aims to see if a new, non-invasive urine test can accurately diagnose pneumonia caused by specific types of bacteria in young children in Malawi. Researchers will test 350 existing urine samples from children, comparing the new test results to standard methods. The goa…